Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Teva Pharmaceutical Industries Ltd (NYSE: TEVA)

$32.76 USD $0.03 (0.09%)
Last Price $32.76
Net Change $0.03 (0.09%)
Bid $0
Ask Price $0
Open Price $32.71
Previous Close Price $32.73
High Price $32.85
Low Price $32.34
Number of Trades 15,598
Volume 4,130,400
Fifty Two Week High $58.16 (2016-04-21)
Fifty Two Week Low $31.9 (2017-02-08)
Average Daily Volume 10,993,754
Share Outstanding 1,014,990 Shares
Total Dividend Payout 1.16/yr
Dividend Yield 3.53%
1st Quarter Earnings $1.38 (2017-02-13)
2nd Quarter Earnings $1.31 (2016-11-15)
3nd Quarter Earnings $1.25 (2016-08-04)
4th Quarter Earnings $1.2 (2016-05-09)
PE Ratio $6.46
EPS Growth $-6.94
Recent Earnings $1.38
Annual EPS $5.07
Last Quarter EPS $
Market Capitalization $33.25B
Insider Shareholders % 0.071%
Annual Revenue $0B
No. Shares Outstanding 1,014,990
Inst. Shareholder % 59%
Annual Net Income $0.33B
TTM Net Profit Margin $1.5
1-Year Return -37.52%
3-Year Return -27.93%
5-Year Return -14.87%
5-Year Revenue Growth 19.61%
5-Year Earnings Growth 1.81%
5-Year Dividend Growth 48.72%
Annual Dividend $1.16
Annual Dividend Yield 3.53%
Change in EPS YTD -6.94%
Dividends per Share $0.289
Stock Split Ratio 2-1
Beta 0.61
TEVA Pharmaceuticals USA the business is to develop manufacture and market generic pharmaceuticals. Teva USA sells its products to chains wholesalers distributors hospitals managed care entities and government agencies. The company markets a variety of dosage forms including both extended and immediate release tablets and capsules creams ointments solutions and suspensions. Key therapeutic areas are the analgesic anti-infective cardiovascular CNS dermatological and anti-inflammatory categories.